April 28, 2022 | Abata News Abata Therapeutics Appoints Sandy Lazzari as Chief People Officer April 6, 2022 | Abata News Abata Announces Formation of Advisory Board Comprised of Leading Industry Experts in Treg Biology, Cell Therapy and Corporate Development December 3, 2021 | Abata News Does It Matter Where You Locate Your Biopharma Anymore? November 9, 2021 | Abata News Treg engineers take aim at autoimmunity November 9, 2021 | Abata News Treg engineers take aim at autoimmunity July 28, 2021 | Abata News Abata Therapeutics Strengthens Board of Directors July 21, 2021 | Abata News A Potential Transformational Therapy for Progressive MS June 23, 2021 | Abata News Cell therapy startup Abata launches with $95 million in funding June 23, 2021 | Abata News How Abata new strategy in non-relapsing MS? Third Rock leads $95M series A